Researchers from the National Institutes of Health have discovered a biomarker in the DNA of five different types of cancerous tumors, as well as evidence that the genetic signature may be present in ...

The Immunotherapy Response Score predicts benefit from anti-PD-1/PD-L1 monotherapy, addressing unmet needs in cancer treatment diagnostics. Developed using Strata trial data, the IRS combines tumor ...

As compared with the conventional clinical development paradigms, where the key is to evaluate treatment effects in histology-defined populations, the choices of biomarker-driven clinical trial ...

Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer Natural language ...